Results 191 to 200 of about 24,520 (233)

The ginger-derived nanovesicles-coated albumin nanoparticles induce cell death and epigenetic regulation to treat colorectal cancer. [PDF]

Discov Nano
Li S, Tian W, Li P, Zhao J, Yao Y, Yuan H.   +5 more
europepmc   +1 more source

CD47 Promotes, While Exposure to Apoptotic Cells Destroys the Fusion Program of Differentiating Myoblasts. [PDF]

FASEB J
Ali MA, Papp AB, Garabuczi É, Gere ÁK, Dienes B, Gönczi M, Vámosi G, Köröskényi K, Csernoch L, Szondy Z, Sarang Z.   +10 more
europepmc   +1 more source

Targeting hypoxic exosomal IGFBP2 overcomes CD47-mediated immune evasion in glioblastoma. [PDF]

Cell Death Dis
Qi Y, Zhao R, Zhang X, Xia H, Zhang P, Wang Q, Zhao S, Wang S, Zhao H, Guo X, Qiu W, Li B, Pan Z, Qiu J, Gao Z, Wang C, Lu H, Li G, Xue H.   +18 more
europepmc   +1 more source

Phase II study of magrolimab combined with docetaxel in previously treated metastatic advanced solid tumors. [PDF]

Front Oncol
Italiano A, García Manrique T, Grande Pulido E, Kerrigan K, Fléchon A, Martínez Pérez J, Żurawski B, Furqan M, Juan-Vidal O, Vaishampayan U, Fares C, Fang B, Vicuna B, Greillier L, Subbiah V, Dong M, Song K, Zhang Y, Kim Y, Paz-Ares L.   +19 more
europepmc   +1 more source

Neutrophil efferocytosis in chronic inflammatory gastrointestinal diseases: mechanistic insights and therapeutic potential. [PDF]

Front Immunol
Ye SY, Qu Y, Zhang JH, Wang XH, Wang JB, Xue YN, Liu JD.   +6 more
europepmc   +1 more source

Immunomodulatory functions of glutaminyl cyclases QPCTL and QPCT. [PDF]

Front Immunol
Smid HE, Colotti J, Nölp S, Arlt NS, Weber S, Gumann A, von Hörsten S, Karow A, Schuh W.   +8 more
europepmc   +1 more source

Breast Cancer Milieu Maneuvers Cancer-Associated Macrophages to Synergize Neoplastic Repertoires. [PDF]

Cancers (Basel)
Lin HJ, Liu Y, Langevin B, Lin J.
europepmc   +1 more source

Elevated IgG levels induce an M2‑to‑M1 phenotypic shift in mucosal macrophages and restrict the growth of invasive sphenoid sinus pituitary adenomas. [PDF]

Mol Med Rep
Li X, Lei Z, Li S, Xu L, Wang Q, Jiang Q, Wang Z, Zhang H, Huang Y, Lei T.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Is CD47 a potentially promising therapeutic target in cardiovascular diseases? — Role of CD47 in cardiovascular diseases

Life Sciences, 2020
CD47 (cluster of differentiation 47) is a ubiquitously expressed transmembrane protein that belongs to the immunoglobulin superfamily. CD47 is both a receptor for the matricellular protein thrombospondin-1 (TSP-1) and a ligand for signal-regulatory protein alpha (SIRPα).
Quanli, Cheng, Junlian, Gu, Binay Kumar, Adhikari, Liguang, Sun, Jian, Sun   +4 more
openaire   +2 more sources

Targeting the Cancer Biomarker CD47: A Review on the Diverse Mechanisms of the CD47 Pathway in Cancer Treatment

Anti-Cancer Agents in Medicinal Chemistry, 2016
CD47 is a widely expressed cell membrane receptor belonging to the immunoglobulin (Ig) superfamily. CD47 is involved in a number of cellular processes, including proliferation, apoptosis, adhesion and migration through interacting with integrin, thrombospondins and SIRPα. CD47 also plays an important role in the immune system and homeostasis. In recent
Liang, Zhang, He, Huang
openaire   +2 more sources